Agephar SRL
1.0 FTEThe score of Agephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Agephar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
Agephar's financial analysis
- Solvency5.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Agephar
Agephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.549.933
- VAT number
- BE1002549933
- Peppol
- Registered · 0208:1002549933 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Nov 2023
- Registered office
- 6900 Marche-en-Famenne
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Agephar (SRL) has been based in Marche-en-Famenne since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 387 € and equity of 22,766 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 5.2%, below the median of its sector (41.5%).
Companies similar to Agephar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Mont-A-Leux Retail sale of pharmaceutical products Ypres · balance sheet 508,078 €
- M. Lambrecht Retail sale of pharmaceutical products Aalst · balance sheet 516,536 €
- Apotheek Lise-Marie Kinnaer Retail sale of pharmaceutical products Aalst · balance sheet 367,043 €
- Demeulenaere Retail sale of pharmaceutical products Roeselare · balance sheet 761,463 €
- Aganju Concept Retail sale of pharmaceutical products Ganshoren · balance sheet 545,205 €
- Ackerman - DE Pauw Retail sale of pharmaceutical products Bruges · balance sheet 872,575 €
- BVV Retail sale of pharmaceutical products Affligem · balance sheet 202,995 €
- Amko International Retail sale of pharmaceutical products Hasselt · balance sheet 151,887 €
Frequently asked questions about Agephar
What is the revenue of Agephar?
Agephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Agephar?
In Belgium, the VAT number is the company number prefixed with BE: BE1002549933 for Agephar, if the company is VAT-registered. Its company number (CBE) is 1002.549.933.
Where is the registered office of Agephar?
According to the CBE register, the registered office of Agephar is in 6900 Marche-en-Famenne.
What is the equity of Agephar?
At the close of the 2025 financial year, the equity of Agephar amounts to 22,766 €, a solvency of 5.2% of total assets.
How many people work at Agephar?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Agephar?
The register lists 2 active mandates at Agephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Agephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →